JAMJOOM PHARMACEUTICALS FACTORY TADAWUL:4015:
JAMJOOM PHARMA H1 DIVIDEND PER SHARE SAR 2.00
Jamjoom Pharma H1 Dividend Per Share SAR 2.00
Jamjoom Pharmaceuticals Factory Co. on 6ix
In the deck
Story so far
Earlier from Jamjoom Pharmaceuticals Factory
- PRESSR: Jamjoom Pharma and the Emirates Dermatology Society join forces to launch “ECZPLORE” – A National Awareness Initiative to help families lead an Eczema-Friendly Life
- Jamjoom Pharma Announces Board Recommendation To Buy-Back Its Shares
- SNG: Saudi: Jamjoom Pharma logs $42mln net profits in Q1-25
Later from Jamjoom Pharmaceuticals Factory
- PRESSR: New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
- Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA
- SNG: Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
- PRESSR: Jamjoom Pharma and Iraqi Dermatology Society sign MoU to transform skin health awareness
- PRESSR: Jamjoom Pharma unveils new brand identity to accelerate regional and global growth
Follow Jamjoom Pharmaceuticals Factory into a list and get an email when it puts out news.
Follow Jamjoom Pharmaceuticals Factory